ADVANTAN Presentation Uses - Medsafe
ADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Download ADVANTAN Presentation Uses - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzRedipred – Data Sheet Page 3 of 11 dosage appear to be important factors in determining suppression of the pituitary adrenal axis and response to stress on cessation of steroid treatment.
Related documents
Lasix Special (furosemide) - Sanofi
products.sanofi.caCorn starch, colloidal silicon dioxide, D&C Yellow #10, FD&C Yellow #6, lactose monohydrate, magnesium stearate, powdered cellulose, sodium starch glycolate and talc.
9. Other Blood Group Systmes - Austin Community College
www.austincc.eduIX. Other Blood Group Systems MLAB 2431 C 85 e. Anti- i is c lassically asso ciated with certain viral diso rders, such as in fect io us mo non ucl eo si s, c aused by the Epstein-Barr virus, and cytomegalovirus (CMV).
Instructions for Use - Galderma
www.galdermausa.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE SOOLANTRA cream is indicated for the treatment of inflammatory lesions of rosacea. 2 DOSAGE AND ADMINISTRATION
New Zealand Data Sheet - Immunisation Advisory Centre
www.immune.org.nz1 New Zealand Data Sheet . BOOSTRIX® Combined diphtheria- tetanus-acellular pertussis (dTpa) vaccine . DESCRIPTION . BOOSTRIX dTpa vaccine is a …
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET . New Zealand Data Sheet Page 2 of 11. A dose of 10 to 20 mg (2 to 4 tablets) by mouth may be given initially and increased as
NEW ZEALAND DATA SHEET PEVARYL 1% w/w Cream
www.medsafe.govt.nzNEW ZEALAND DATA SHEET PEVARYL 1% w/w Cream PEVARYL Cream Page 3 of 5 Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of …
Classification of the causative agent Resistance to ...
www.oie.int1 RIFT VALLEY FEVER Aetiology Epidemiology Diagnosis Prevention and Control References AETIOLOGY Classification of the causative agent Rift Valley fever (RVF) virus is a negative-sense, single-stranded RNA virus of the family Bunyaviridae